JAMA Cardiology
Original Investigation
April 17, 2024
Yi听Li,听MD; Jing听Li,听MD; Bin听Wang,听MD; Quanmin听Jing,听MD; Yujie听Zeng,听MD; Aijie听Hou,听MD; Zhifang听Wang,听MD; Aijun听Liu,听MD; Jinliang听Zhang,听MD; Yaojun听Zhang,听MD; Ping听Zhang,听MD; Daming听Jiang,听MD; Bin听Liu,听MD; Jiamao听Fan,听MD; Jun听Zhang,听MD; Li听Li,听MD; Guohai听Su,听MD; Ming听Yang,听MD; Weihong听Jiang,听MD; Peng听Qu,听MD; Hesong听Zeng,听MD, PhD; Lu听Li,听MD; Miaohan听Qiu,听MD; Leisheng听Ru,听MD; Shaoliang听Chen,听MD; Yujie听Zhou,听MD; Shubin听Qiao,听MD; Gregg W.听Stone,听MD; Dominick J.听Angiolillo,听MD, PhD; Yaling听Han,听MD; OPT-BIRISK Investigators
online first
JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0534
This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.
JAMA
Original Investigation
April 7, 2015
Yaling听Han,听MD, PhD; Jincheng听Guo,听MD; Yang听Zheng,听MD; Hongyun听Zang,听MD; Xi听Su,听MD; Yu听Wang,听MD; Shaoliang听Chen,听MD; Tiemin听Jiang,听MD; Ping听Yang,听MD; Jiyan听Chen,听MD; Dongju听Jiang,听MD; Quanmin听Jing,听MD; Zhenyang听Liang,听MBBS; Haiwei听Liu,听MD; Xin听Zhao,听MD; Jing听Li,听MBBS; Yi听Li,听MD; Bo听Xu,听MBBS; Gregg W.听Stone,听MD; for the BRIGHT Investigators
free access
JAMA. 2015; 313(13):1336-1346. 10.1001/jama.2015.2323
This randomized superiority trial in China found that among patients undergoing PCI, bivalirudin was associated with reduced adverse effects compared with heparin alone and heparin plus tirofiban.